ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer

Autor:	R.L. Coleman, K. Fujiwara, J. Sehouli, V. Salutari, P. Zola, R. Madry, J. Korach, P. Pautier, D. Cibula, S. Lheureux, K. Hasegawa, B.G. Kim, C.H. Lai, A. Gonzalez-Martinez, Q. Liu, S. Keefe, M. Puglisi, S. Topuz, B.J. Monk, R.C. Arend, D.M. O'Malley, I. Vergote
Rok vydání:	2020
Předmět:	Oncology Obstetrics and Gynecology
Zdroj:	Gynecologic Oncology. 159:89-90
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2020.05.070
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b89fcaeb965968eaa8135918672cd2a6 https://doi.org/10.1016/j.ygyno.2020.05.070 Zobrazit plný text záznamu Full Text from ScienceDirect